Virulence characteristics of Escherichia coli strains causing asymptomatic bacteriuria

Infection

Volumn 31, Issue 4, 2003, Pages 216-220

  Vranes J ^a   Kruzic V ^a   Sterk Kuzmanovic N ^a   Schonwald S ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYSIN; VIRULENCE FACTOR;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; CHILD; ESCHERICHIA COLI; FEMALE; HEMAGGLUTINATION; HEMOLYSIS; HUMAN; NONHUMAN; PROTEIN EXPRESSION; RECURRENT INFECTION; URINARY TRACT INFECTION;

ESCHERICHIA COLI;

EID: 0041657624     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-003-2069-x     Document Type: Article

References (15)

1. Johnson JR: Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4: 80-128.
2. Vraneš J: Virulence properties of Escherichia coli strains isolated in different forms of urinary tract infection. In: Fünfstück R, Straube E, Stein G (eds): Harnwegsinfektion. Pathogenetische, klinische und therapeutische aspekte. Pabst Science Publishers, Langerich 1997, pp 36-43.
3. Oelschlaeger TA, Dobrindt U, Hacker J: Virulence factors of uropathogens. Curr Opin Urol 2002; 12: 33-38.
4. Guyer DM, Gunther NW, Mobley HLT: Secreted proteins and other features specific to uropathogenic Escherichia coli. J Infect Dis 2001; 183 (suppl 1): 32-35.
5. Rippere-Lampe KE, O'Brian AD, Conran R, Lockman HA: Mutation of the gene encoding cytotoxic necrotizing factor type 1 (CNF 1) attenuates the virulence of uropathogenic Escherichia coli. Infect Immun 2001; 69: 3954-3964.
6. Hull RA, Rudy DC, Donovan WH, Wieser IE, Stewart C, Darouiche RO: Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun 1999; 67: 429-432.
7. O'Hanley P, Lalonde G, Ji G: Alpha-hemolysin contributes to the pathogencity of piliated digalactoside-binding Escherichia coli in the kidney: Efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis. Infect Immun 1991; 59: 1153-1161.
8. Vranes J: Hemagglutination ability and adherence to the Buffalo green monkey kidney cell line of uropathogenic Escherichia coli. APMIS 1997; 105: 831-837.
9. Bauer AW, Kirby WMM, Sherris JC, Turck M: Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45: 493-496.
10. Hagberg L, Jodal U, Korhonen TK, Lidin-Jansen G, Linberg U, Svanborg Edén C: Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun 1981; 31: 564-570.
11. Andersson P, Engberg I, Lidin-Janson, Lincoln K, Hull R, Hull S, Svanborg C: Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun 1991; 59: 2915-2921.
12. Hanson S, Jodal U, Norén L, Bjure J: Outcome of untreated asymptomatic bacteriuria in girls with renal scarring. Pediatrics 1989; 84: 964-968.
13. Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999; 281: 736-738.
14. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW: Widespread distribution of urinary tract infections caused by multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001; 345: 1007-1013.
15. Marild S, Wettergren B, Hellström M, Jodal U, Lincoln K, Ørskov I, Ørskov F, Svanborg Edén: Bacterial virulence and inflammatory response in infants with febrile urinary tract infection or screening bacteriuria. J Pediatr 1988; 112: 348-354.